Dr Chandni Hindocha

UCL RESEARCH FELLOW

Dr Hindocha is an internationally award-winning research fellow at University College London (UCL) who is currently exploring how our DNA affects how we respond to cannabis.

Zack Bellman

GLASS LEAF Scientist & educator

Neuroscience (BSc 2.1.) from the University of Sussex and a Masters of Research in Drug Sciences (MRes Distinction specialising in Pharmaceutical Biology & Ethnopharmacy of Cannabis) from the University College London School of Pharmacy.

Chelsea Leyland

‘SEPARATING THE STRAINS’ DOCUMENTARY Deejay & activist

Chelsea suffers from a type of epilepsy called ‘Juvenile Myoclonic Epilepsy’, which she has been battling since her early teenage years. Chelsea has been treating her epilepsy with Cannabidiol, having weaned herself off pharmaceutical drugs.

Jade Green

Jade Green Consulting

Jade has worked as a consultant to multiple private and publicly-traded cannabis companies on operational strategy an expansion initiatives.

Elisabetta Faenza

Co-Founder and CEO LeafCann Group

Elisabetta's journey was prompted by a childhood diagnosis of a rare and normally deadly genetic condition, which led her on a quest to understand how our bodies, medicines, nutrition and the environment interact to switch damaging genes on and off.

Dr Callie Seaman

HONORARY RESEARCHER AT SHEFFIELD HALLAM UNIVERSITY

A veteran of the hydroponic industry. Degree in Biomedical Sciences at Sheffield Hallam University, during which she worked at GlaxoSmithKline, she went on to complete a PhD on The Investigating nutrient solution for hydroponic growth of plants.

Basia Zieniewicz

Co-founder of CannPASS, Families4Access & CANNTalks

Basia is a co-founder of Families4Access and a range of creative and cooperative initiatives in Canada, USA, and the UK. Founding Team for the Centre for Medicinal Cannabis. Creative Director for various campaigns and small organisations.

Jonathan Liebling

Co-founder & Director to CannPASS Research Lead to the Centre for Medicinal Cannabis

Jon spent 5 years as Political Director for United Patients Alliance, a patient-led, volunteer organisation who provide support for medical cannabis patients whilst campaigning for legal access in the UK.

Derek Tracy

FRCPSYCH, CONSULTANT PSYCHIATRIST & CLINICAL DIRECTOR / OXLEAS NHS FOUNDATION TRUST, LONDON / KING’S COLLEGE LONDON

Derek Tracy is a Consultant Psychiatrist and Clinical Director at Oxleas NHS Foundation Trust, London. His directorate is a nationally innovative integrated model encompassing adult social care, mental and physical health services.

Carly Barton

Carly is a former Lecturer in the Arts who has a creative background that includes exhibiting at the Tate and the Saatchi gallery. After having to give up her role due to health problems, she discovered that Medical Cannabis was not only an appropriate but more effective substitute for Opioids

Jessica Steinberg

CANNTalks Content Strategy & Social Responsibility UNIVERSITY OF OXFORD PhD

Jessica Steinberg is a PhD student at the University of Oxford. Her research explores the global effort of cannabis policy reform through the lens of the legal, regulated industry.

Caroline Sharp

PHIL BRISTOL / NEUROSCIENCE UCL / DIRECTOR ‘SEPERATING THE STRAINS’

Caroline is a film-maker based in London whose current project is a feature-length documentary, Separating the Strains, which she has produced and directed.

Dr Andy Yates

Honorary Lectureship at Keele University and is the Pharmacy Lead for the Centre for Medicinal Cannabis

Andy has over 15 years of pharma experience working in the medical, commercial, business development and strategy functions.

Dr Saoirse O’Sullivan

University of Nottingham Associate Professor Science Lead, Centre for Medicinal Cannabis

Dr Saoirse O’Sullivan has been researching the role and effects of endocannabinoids and phytocannabinoids through basic and clinical research for 16 years.

Blair Gibbs

Blair is a political consultant and former senior advisor in the UK government. He saw up close how current drug laws and prohibition impacts society and undermines the justice and healthcare systems.

Dan Couch

MB ChB MRCS MBA PhD

Daniel Couch completed his medical degree in 2007, graduating from the University of Leicester, and has worked internationally in General Surgery after achieving membership of the Royal College of Surgeons in 2011.

Diane Scott

CHAIR & CHIEF EXECUTIVE OFFICER JAMAICAN MEDICAL CANNABIS CORPORATION (JMCC)

Described by Forbes as the company’s “savvy CEO”, Diane Scott brings over 20 years of global experience in the C-suite of enterprises in global emerging industries to her role of Chair and CEO of JMCC.

Hilary Black

Chief Advocacy Officer, Canopy Growth & Founder BC Compassion Club Society, Canada’s first medical cannabis dispensary

As Chief Advocacy Officer at Canopy Growth, Hilary is responsible for patient advocacy worldwide, corporate social responsibility, and implementation of best practices for diversity & inclusion.

David Nutt

DM, FRCP, FRCPsych, FMedSci, DLaws Founder Chair of Drug Science

David Nutt is currently the Edmund J Safra Professor of Neuropsychopharmacology and Head of the Neuropsychopharmacology Unit in the Centre for Academic Psychiatry in the Division of Brain Sciences, Dept of Medicine, Hammersmith Hospital, Imperial College London. He is also visiting professor at the Open University in the UK and Maastricht University in the Netherlands.

Dr Mark Ware

Chief Medical Officer of Canopy Growth Corporation

Dr Mark Ware is currently the Chief Medical Officer of Canopy Growth Corporation. He has taken a leave of absence as Associate Professor in Family Medicine and Anaesthesia at McGill University from July 2018 to work in this capacity. He previously served as Director of Clinical Research of the Alan Edwards Pain Management Unit at the McGill University Health Centre for over 10 years and was the Executive Director of the non-profit Canadian Consortium for the Investigation of Cannabinoids since 2007.